- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/745 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class C07K 14/745
Total number of patents in this class: 716
10-year publication summary
|
48
|
45
|
52
|
50
|
49
|
51
|
25
|
26
|
25
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2711 |
22 |
| Modernatx, Inc. | 1259 |
18 |
| The Children's Hospital of Philadelphia | 789 |
17 |
| Bioverativ Therapeutics Inc. | 215 |
15 |
| Opko Biologics Ltd. | 77 |
13 |
| Immunitybio, Inc. | 382 |
13 |
| CSL Behring GmbH | 344 |
11 |
| The University of North Carolina at Chapel Hill | 2046 |
11 |
| Yale University | 2399 |
11 |
| Gladiator Biosciences, Inc. | 14 |
11 |
| CSL Limited | 256 |
10 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 296 |
10 |
| Novo Nordisk Health Care AG | 341 |
9 |
| Alexion Pharmaceuticals, Inc. | 636 |
8 |
| Case Western Reserve University | 1826 |
8 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3362 |
8 |
| Amunix Pharmaceuticals, Inc. | 81 |
8 |
| Affibody AB | 115 |
7 |
| Baxter International Inc. | 2406 |
6 |
| Baxter Healthcare S.A. | 1833 |
6 |
| Other owners | 494 |